1. Home
  2. TNXP vs FTK Comparison

TNXP vs FTK Comparison

Compare TNXP & FTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • FTK
  • Stock Information
  • Founded
  • TNXP 2007
  • FTK 1985
  • Country
  • TNXP United States
  • FTK United States
  • Employees
  • TNXP N/A
  • FTK N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • FTK Major Chemicals
  • Sector
  • TNXP Health Care
  • FTK Industrials
  • Exchange
  • TNXP Nasdaq
  • FTK Nasdaq
  • Market Cap
  • TNXP 335.6M
  • FTK 336.2M
  • IPO Year
  • TNXP N/A
  • FTK N/A
  • Fundamental
  • Price
  • TNXP $22.41
  • FTK $16.37
  • Analyst Decision
  • TNXP Buy
  • FTK Buy
  • Analyst Count
  • TNXP 1
  • FTK 2
  • Target Price
  • TNXP $70.00
  • FTK $12.00
  • AVG Volume (30 Days)
  • TNXP 1.1M
  • FTK 531.0K
  • Earning Date
  • TNXP 11-11-2025
  • FTK 11-04-2025
  • Dividend Yield
  • TNXP N/A
  • FTK N/A
  • EPS Growth
  • TNXP N/A
  • FTK 82.12
  • EPS
  • TNXP N/A
  • FTK 0.43
  • Revenue
  • TNXP $9,831,000.00
  • FTK $214,211,000.00
  • Revenue This Year
  • TNXP $14.79
  • FTK $19.47
  • Revenue Next Year
  • TNXP $933.49
  • FTK $11.22
  • P/E Ratio
  • TNXP N/A
  • FTK $37.18
  • Revenue Growth
  • TNXP N/A
  • FTK 21.72
  • 52 Week Low
  • TNXP $6.76
  • FTK $4.70
  • 52 Week High
  • TNXP $130.00
  • FTK $17.93
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 30.44
  • FTK 63.68
  • Support Level
  • TNXP $23.60
  • FTK $15.02
  • Resistance Level
  • TNXP $29.19
  • FTK $17.93
  • Average True Range (ATR)
  • TNXP 1.63
  • FTK 1.02
  • MACD
  • TNXP 0.12
  • FTK 0.29
  • Stochastic Oscillator
  • TNXP 5.31
  • FTK 64.60

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About FTK Flotek Industries Inc.

Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.

Share on Social Networks: